Everett Cunningham
CIK 1564777 · President and CEO · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.71M
Companies
5
Total Filings
55
Lifetime Open-Market Net
-$22.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARVN | Director | 41,572 | $8.06 | $335.1K | $0 | 5 | 2026-06-26 |
| QTRX | President and CEO | — | $3.71 | — | $0 | 1 | 2026-01-21 |
| ILMN | SVP, Chief Commercial Officer | 42,614 | $198.16 | $8.44M | $0 | 3 | 2025-07-08 |
| EXACT SCIENCES CORP (EXAS) Delisted | Chief Commercial Officer | 47,041 | $104.91 | $4.94M | -$2.06M | 10 | 2024-05-02 |
| DGX | SVP, Commercial | 38,481 | $231.95 | $8.93M | -$20.61M | 31 | 2019-03-25 |
Recent Filings · Page 2 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-01 | EXACT SCIENCES CORP (EXAS) Delisted | Notice (144) | −2,412 | -$143.1K | EDGAR |
| 2024-02-28 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +4,030 | -$207.5K | EDGAR |
| 2024-02-27 | EXACT SCIENCES CORP (EXAS) Delisted | Notice (144) | −3,648 | -$207.5K | EDGAR |
| 2024-02-23 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,361 | -$80.7K | EDGAR |
| 2024-02-22 | EXACT SCIENCES CORP (EXAS) Delisted | Notice (144) | −1,350 | -$80.7K | EDGAR |
| 2023-10-13 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +15,206 | -$843.6K | EDGAR |
| 2023-10-12 | EXACT SCIENCES CORP (EXAS) Delisted | Notice (144) | −13,007 | -$864.8K | EDGAR |
| 2023-06-20 | ARVN | Grant (A) | +4,121 | $0 | EDGAR |
| 2023-03-02 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −3,628 | -$225.0K | EDGAR |
| 2023-03-01 | EXACT SCIENCES CORP (EXAS) Delisted | Exer (M) | +7,677 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.